|
Saliva Diagnostic Systems, Inc. - Comparative Business Analysis Snapshot
Business Description
Saliva Diagnostic Systems, Inc.. The Company's principal activity is the development, manufacture and marketing of rapid immunoassays for use in the detection of infectious diseases and medical specimen collection devices. The Company's products fall into two categories: Rapid Immunoassays and Medical specimen collection devices. The Company has developed four rapid tests utilizing immunochromatography for the detection of antibodies to selected pathogens, including HIV and Helicobacter pylori. Rapid immunoassays products include Sero-Strip HIV, Hema-Strip HIV and Saliva-Strip HIV. Medical specimen collection device includes Omni SAL(R). This product is a patented saliva collection device currently sold to several commercial companies for use with their laboratory assays for the detection of HIV infection, drugs-of-abuse and cigarette smoking. The Company markets its products in the United States, the United Kingdom, Canada, Caribbean, Asia and Africa.
Competitor Analysis
This analysis compares Saliva Diagnostic Systems, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
